Epstein Secrets

SA World Economic Forum Annual Meeting EFTA R1_02010994 EFTA02686120 David T. Ellwood Thomas Enders Ditlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Escobar Shelly Esque Dan Esty John Evans Stuart Evans Bob Every Dean Chief Executive Officer

of the Board of Managing Directors Chief Executive Chief Executive Officer and Editor-in-Chief Clarence James Gamble Professor of Economics and Demography Chief Executive Officer Dean Deputy Managing Editor Founder and Chief Executive Officer Member of the Board, Chief Financial Officer and Chairm

d Systems A/S Denmark Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charle

nnual Meeting 2011 EFTA_R1_02011048 EFTA02686173 David E. Bloom Clarence James Gamble Professor of Harvard School of Public USA Economics and Demography Health Kathy Bloomgarden Chief Executive Officer Ruder Finn Inc. USA Sally Blount Dean Kellogg School of USA Management Rebecca Blumenstei

d Systems A/S Denmark Klaus Engel Chief Executive Officer Evonik Industries AG Germany Richard P. Eno Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland Mary Callahan Erdoes Chief Executive Officer, Asset JPMorgan Chase & Co. USA Management Charle

nnual Meeting 2011 EFTA_R1_02011167 EFTA02686250 David E. Bloom Clarence James Gamble Professor of Harvard School of Public USA Economics and Demography Health Kathy Bloomgarden Chief Executive Officer Ruder Finn Inc. USA Sally Blount Dean Kellogg School of USA Management Rebecca Blumenstei